Daniel R. Pilipauskas

Person

Glenview, IL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Process for the preparation of ethyl 3S-[[4-[[4-(aminoiminomethyl)p...
- Patent number 5,631,399
- Issue date May 20, 1997
- G. D. Searle & Co.
- Kevin A. Babiak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of ethyl 3S-[4-[[4-(aminoiminomethyl)ph...
- Patent number 5,536,869
- Issue date Jul 16, 1996
- G. D. Searle & Co.
- Kevin A. Babiak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
O-substituted tyrosyl dipeptide amides
- Patent number 4,797,470
- Issue date Jan 10, 1989
- G. D. Searle & Co.
- Barnett S. Pitzele
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted tyrosyl methionyl dipeptide amides
- Patent number 4,767,744
- Issue date Aug 30, 1988
- G. D. Searle & Co.
- Donald W. Hansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-terminally substituted dipeptide amides
- Patent number 4,760,180
- Issue date Jul 26, 1988
- G. D. Searle & Co.
- Barnett S. Pitzele
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfide, sulfinyl and sulfone dipeptide amides
- Patent number 4,757,153
- Issue date Jul 12, 1988
- G. D. Searle & Co.
- Donald W. Hansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted tyrosyl alanine dipeptide amides
- Patent number 4,727,189
- Issue date Feb 23, 1988
- G. D. Searle & Co.
- Donald W. Hansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted tyrosyl alanine dipeptide amides
- Patent number 4,599,325
- Issue date Jul 8, 1986
- G. D. Searle & Co.
- Donald W. Hansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Eplerenone Drug Substance Having High Phase Purity
- Publication number 20090149431
- Publication date Jun 11, 2009
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone crystalline form exhibiting enhanced dissolution rate
- Publication number 20050267302
- Publication date Dec 1, 2005
- G.D. Searle & Co.
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone drug substance having high phase purity
- Publication number 20050261261
- Publication date Nov 24, 2005
- Pharmacia Corporation
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone crystal form exhibiting enhanced dissolution rate
- Publication number 20050159594
- Publication date Jul 21, 2005
- Pharmacia Corporation
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone drug substance having high phase purity
- Publication number 20030083493
- Publication date May 1, 2003
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone crystalline form
- Publication number 20020045746
- Publication date Apr 18, 2002
- Kathleen P. Barton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Eplerenone crystalline form exhibiting enhanced dissolution rate
- Publication number 20020038021
- Publication date Mar 28, 2002
- Kathleen P. Barton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Daniel R. Pilipauskas

Person

Patents Grantslast 30 patents

Process for the preparation of ethyl 3S-[[4-[[4-(aminoiminomethyl)p...

Process for the preparation of ethyl 3S-[4-[[4-(aminoiminomethyl)ph...

O-substituted tyrosyl dipeptide amides

Substituted tyrosyl methionyl dipeptide amides

N-terminally substituted dipeptide amides

Sulfide, sulfinyl and sulfone dipeptide amides

Substituted tyrosyl alanine dipeptide amides

Substituted tyrosyl alanine dipeptide amides

Patents Applicationslast 30 patents

Eplerenone Drug Substance Having High Phase Purity

Eplerenone crystalline form exhibiting enhanced dissolution rate

Eplerenone drug substance having high phase purity

Eplerenone crystal form exhibiting enhanced dissolution rate

Eplerenone drug substance having high phase purity

Eplerenone crystalline form

Eplerenone crystalline form exhibiting enhanced dissolution rate